» Articles » PMID: 37726802

Comparison of Huntington's Disease Phenotype Progression in Male and Female Heterozygous FDNQ175 Mice

Overview
Journal Mol Brain
Publisher Biomed Central
Date 2023 Sep 19
PMID 37726802
Authors
Affiliations
Soon will be listed here.
Abstract

Huntington's Disease (HD) is an inherited autosomal dominant neurodegenerative disorder that leads to progressive motor and cognitive impairment due to the expansion of a polyglutamine (CAG) repeat in the N-terminal region of the huntingtin (Htt) protein. The creation of HD mouse models represents a critical step in the research for HD treatment. Among the currently available HD mouse models, the zQ175 knock-in mouse line is the first to display robust disease phenotype on a heterozygous background. The newer FDNQ175 mouse model is derived from the zQ175 mouse line and presents a more aggressive phenotype. Moreover, increasing evidence has implicated sex as a contributing factor in the progression of HD symptoms. Here, we compared the progression of HD phenotypes in male and female heterozygous FDNQ175 mice. We found that both male and female heterozygous mice showed deficits in forelimb grip strength and cognition as early as 6 months of age. However, female FDNQ175 mice were less vulnerable to HD-associated decline in limb coordination and movement. Neither male nor female FDNQ175 mice exhibited reduced locomotor activity in the open field or exhibit consistent differences in anxiety at 6-12 months of age. Both male and female FDNQ175 mice exhibited increased numbers of huntingtin aggregates with age and 8-month-old female FDNQ175 mice had significantly more aggregates than their male counterparts. Taken together, our results provide further evidence that sex can influence the progression of HD phenotype in preclinical animal models and must be taken into consideration for future HD research.

Citing Articles

A bacterial artificial chromosome mouse model of amyotrophic lateral sclerosis manifests 'space cadet syndrome' on two FVB backgrounds.

Badger S, Coldicott I, Kyrgiou-Balli E, Higginbottom A, Moutin C, Mohd Imran K Dis Model Mech. 2025; 18(2).

PMID: 39945358 PMC: 11849976. DOI: 10.1242/dmm.052221.


Deep behavioural phenotyping of the Q175 Huntington disease mouse model: effects of age, sex, and weight.

Koch E, Cheng J, Ramandi D, Sepers M, Hsu A, Fong T BMC Biol. 2024; 22(1):121.

PMID: 38783261 PMC: 11119712. DOI: 10.1186/s12915-024-01919-9.

References
1.
Bode F, Stephan M, Suhling H, Pabst R, Straub R, Raber K . Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males. Hum Mol Genet. 2008; 17(17):2595-609. DOI: 10.1093/hmg/ddn159. View

2.
de Souza J, Ferreira-Vieira T, Maciel E, Silva N, Lima I, Doria J . mGluR5 ablation leads to age-related synaptic plasticity impairments and does not improve Huntington's disease phenotype. Sci Rep. 2022; 12(1):8982. PMC: 9148310. DOI: 10.1038/s41598-022-13029-z. View

3.
Ferrante R . Mouse models of Huntington's disease and methodological considerations for therapeutic trials. Biochim Biophys Acta. 2009; 1792(6):506-20. PMC: 2693467. DOI: 10.1016/j.bbadis.2009.04.001. View

4.
Roos R . Huntington's disease: a clinical review. Orphanet J Rare Dis. 2010; 5:40. PMC: 3022767. DOI: 10.1186/1750-1172-5-40. View

5.
Yang S, Cheng P, Banta H, Piotrowska-Nitsche K, Yang J, Cheng E . Towards a transgenic model of Huntington's disease in a non-human primate. Nature. 2008; 453(7197):921-4. PMC: 2652570. DOI: 10.1038/nature06975. View